Trial Details

COMPLETED
Basic Information
Clinical ID c4606
Identifier NCT00267722
Trial Title Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Visilizumab
Participant Information
Sponsor Facet Biotech
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2005-02
Primary Completion Date 2006-12
Completion Date 2006-12